CoChat

Strategies for obtaining unpublished drug trial data: a qualitative interview study

Open access
Wolfe, Nicole, Gøtzsche, Peter C, Bero, Lisa · 2013 · Systematic Reviews

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Background: Authors of systematic reviews have difficulty obtaining unpublished data for their reviews. This project aimed to provide an in-depth description of the experiences of authors in searching for and gaining access to unpublished data for their systematic reviews, and to give guidance on best practices for identifying, obtaining and using unpublished data. Methods: This is a qualitative study analyzing in-depth interviews with authors of systematic reviews who have published Cochrane reviews or published systematic reviews outside of The Cochrane Library. We included participants who 1) were the first or senior author of a published systematic review of a drug intervention, 2) had expertise in conducting systematic reviews, searching for data, and assessing methodological biases, and 3) were able to participate in an interview in English. We used non-random sampling techniques to identify potential participants. Eighteen Cochrane authors were contacted and 16 agreed to be interviewed (89% response rate). Twenty-four non-Cochrane authors were contacted and 16 were interviewed (67% response rate). Results: Respondents had different understandings of what was meant by unpublished data, including specific outcomes and methodological details. Contacting study authors was the most common method used to obtain unpublished data and the value of regulatory agencies as a data source was underappreciated. Using the data obtained was time consuming and labor intensive. Respondents described the collaboration with other colleagues and/or students required to organize, manage and use the data in their reviews, generally developing and using templates, spreadsheets and computer programs for data extraction and analysis. Respondents had a shared belief that data should be accessible but some had concerns about sharing their own data. Respondents believed that obtaining unpublished data for reviews has important public health implications. There was widespread support for government intervention to ensure open access to trial data. Conclusions: Respondents uniformly agreed that the benefit of identifying unpublished data was worth the effort and was necessary to identify the true harms and benefits of drugs. Recent actions by government, such as increased availability of trial data from the European Medicines Agency, may make it easier to acquire critical drug trial data.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/2046-4053-2-31

Cites

30 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Participant flowchart.
Figure 1 Participant flowchart.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 2

  1. Lefebvre C, Manheimer E, Glanville J: Chapter 6: Searching for studies. In Cochrane Handbook for Systematic Reviews of Interventions. Edited by Higgins J, Green S. The Cochrane Collaboration;: Published by The Cochrane Collaboration and John Wiley and Sons Ltd. 2011, England: Chichester
  2. EMA: Access to clinical-trial data and transparency: Workshop report. Agency moves towards proactive publication of clinical-trial data. 2012, London: European Medicines Agency,http://www.ema.europa.eu/docs/en_GB/document_library/Report/2012/12/WC500135841.pdf,

Cited by

See all 30

Metadata

Authors
Wolfe, N., Gøtzsche, P. C., & Bero, L.
Affiliations
  • University of California, San Francisco (US)
  • Rigshospitalet (DK)
Corresponding author
Bero, Lisa
Venue
Systematic Reviews
Published
2013-05-16
Volume
2
Issue
1
Pages
31-31
ISSN
2046-4053 (ISSN-L)
OpenAlex
W2170339327
Cited by
30
References
31
Citations by year
2026: 1 · 2024: 5 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 3
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • Systematic Reviews (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
  • Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
Keywords
data access, data extraction, data sharing, European Medicines Agency, drug safety
MeSH terms
Attitude, Cooperative Behavior, Data Collection, Pharmaceutical Preparations, Humans, Interviews as Topic, Publishing, Review Literature as Topic, Access to Information, Comprehension, Information Dissemination, Qualitative Research, Data Mining

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Strategies for obtaining unpublished drug trial data: a qualitative interview study. https://app.cochat.ai/papers/10.1186/2046-4053-2-31
The paper
Wolfe, N., Gøtzsche, P. C., & Bero, L. (2013). Strategies for obtaining unpublished drug trial data: a qualitative interview study. Systematic Reviews. https://doi.org/10.1186/2046-4053-2-31

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.